Latest News on Pfizer Inc. (PFE) Stock

  • MedGenesis Enters Into Agreement with Pfizer Inc. for Potential Treatments for ... [September 16 2014 06:23 AM]
  • MedGenesis Enters Into Agreement with Pfizer Inc. for Potential Treatments for ...   MarketWatch - Sep 16, 2014 VICTORIA, BRITISH COLUMBIA, Sep 16, 2014 (Marketwired via COMTEX) -- MedGenesis Therapeutix Inc. ("MedGenesis"), a privately held biotechnology company focused on the development and precision delivery of definitive treatments for neurologic ... Read more about this Pfizer Inc. (PFE) news
  • Pfizer Inc. (PFE) Tops DJIA Gainers for September 15 [September 15 2014 01:34 PM]
  • Pfizer Inc. (PFE) Tops DJIA Gainers for September 15   Equities.com - Sep 15, 2014 The Dow closed at 17,031.10 on Monday, which is a 0.26% move from yesterday's close. Pfizer Inc. led all gainers with a 1.67% jump. Investors Purchase High Volume of Put Options on Pfizer (PFE) - Watch List News (press release)  Read more about this Pfizer Inc. (PFE) news


  • Pfizer Drops Plan to Acquire AstraZeneca; Considering Other Options [September 12 2014 04:15 AM]
  • Pfizer Drops Plan to Acquire AstraZeneca; Considering Other Options   Bidness ETC - Sep 12, 2014 It seems like Pfizer Inc. (PFE) has already given up hopes to acquire AstraZeneca plc (ADR) (AZN). The company last made a $116 billion proposal to buy the London-based drug maker only to be spurned by AstraZeneca for undervaluing the company. Stock Alert: Pfizer Inc. (NYSE:PFE), AstraZeneca PL... Read more about this Pfizer Inc. (PFE) news


  • Key Growth Drivers For Pfizer Inc. [September 11 2014 03:30 PM]
  • Key Growth Drivers For Pfizer Inc.   Bidness ETC - Sep 11, 2014 ENBREL was released as a co-promotion campaign by Pfizer and Amgen, Inc. (AMGN) last year. Pfizer's rights to ENBREL expired last year, after which it went back to Amgen. Read more about this Pfizer Inc. (PFE) news
  • French cancer immunotherapy specialist OSE Pharma prepares IPO [September 18 2014 05:25 AM]
  • [Reuters - UK Focus] - French cancer immunotherapy specialist OSE Pharma has registered with market regulator AMF for an initial public offering aimed at financing late-stage trials of its Texopi drug for the most common form ... Read more about this Pfizer Inc. (PFE) news

Looking for Market Opportunties?


Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center